Quordata stands as an AI-driven investment research powerhouse, simplifying the intricate realm of investment decision-making by delivering real-time, actionable insights harvested from the vast landscape of online text.
At the heart of Quordata’s prowess lies its arsenal of custom dashboards, articulate plain-English explanations, and AI-fueled insights that empower users to make sound financial decisions. With Quordata at their disposal, users can seamlessly analyze text culled from diverse sources, ranging from the dynamic discourse of Twitter and Reddit to the professional exchanges on LinkedIn and the Wall Street Journal.
The tool’s backbone is fortified by a proprietary ensemble of spam, sentiment, and biterm topic models, which diligently process and dissect aggregated text, yielding invaluable key metrics. These metrics are elegantly presented within robust dashboards, offering an executive summary replete with AI-driven elucidations, closely affiliated topics, and a detailed breakdown of data sources.
Quordata has garnered accolades from users who hail its capacity to bolster trading confidence, serve up easily digestible information, and efficiently track public sentiment. Catering to a diverse user base, Quordata offers both Basic and Pro plans. The Basic plan extends access to real-time social sentiment metrics for up to 10 companies each month, basic analysis tools for publicly traded companies, and admission to a burgeoning community of kindred investors.
For those seeking more comprehensive insights, the Pro plan, available via a monthly subscription, opens the door to unlimited access to real-time sentiment metrics encompassing all publicly traded companies. It also grants access to advanced AI-powered analyses, actionable insights, and priority privileges for new features and updates.
In essence, Quordata’s mission is to equip investors of all proficiency levels with unparalleled AI-driven investment research tools, thus streamlining their research endeavors and empowering them to forge well-informed investment decisions.